London-headquartered Semble (formerly Heydoc) is an integrated clinical system that allows healthcare businesses of all sizes to manage every aspect of their practice. Now, raised $15 million in a Series B funding round led by Mercia Ventures (which recently invested in Luminous XR and Alesi Surgical), with participation from Octopus Ventures (which recently backed Cambri and DRIFT Energy), Smedvig Ventures, and Triple Point. With this round, the total funding raised by the company accounts for $27 million.
The investment will enable the company to consolidate its position in the UK market and expand its presence in France, where it launched earlier this month. The funding will also allow it to remain at the forefront of innovation by further driving automation and integration capabilities, covering the needs of small and large operators, and harnessing the power of AI.
All-in-one clinical system
Semble was founded by second-time founders – Christoph Lippuner and Mikael Landau in 2018, after successfully exiting their previous startup. Having witnessed firsthand the challenges in the healthcare sector, they founded Semble with the conviction that reducing the administrative burden on medical professionals and fostering a more connected ecosystem would lead to better patient outcomes.
In the UK, the current healthcare system relies on outdated technology to function, with a report from the British Medical Association estimating that doctors in England lose 13.5 million working hours a year to inadequate IT systems. Semble is on a mission to change this through its all-in-one clinical system. The system enables healthcare businesses to automate tasks while providing secure patient data exchange by integrating with third-party systems, such as hospitals, laboratories, and pharmacies. This allows for greater adaptability in the delivery of patient care.
Its platform is now being used by over 10,000 healthcare professionals across more than 70 specialties. It is a market leader amongst independent clinics and is increasingly being adopted by large operators as they seek ways to enhance efficiency and integrate their systems with an agile solution.
Christoph Lippuner, CEO, said: “Amplifying the impact of healthcare professionals is central to our mission. For too long, they have worked with outdated systems that take them away from what matters most – the patient. With this latest funding, we are looking to bring Semble to professionals across the UK and France, empowering them to spend more time on patient care. We will continue to invest heavily in workflow automation and integrations, positioning Semble at the forefront of AI-driven solutions, and ultimately creating a more connected healthcare ecosystem.”
Alex Gwyther of Mercia Ventures added: “The healthcare market is experiencing significant growth, but the industry’s continued reliance on legacy systems poses a real threat to its future. Semble is pioneering an all-in-one clinical system that enables healthcare businesses to automate many aspects of their practice. This investment will help Semble accelerate product development and expand its presence in the UK and France, empowering healthcare organisations to deliver on their digital transformation and transform their patients’ experience. With the founders’ first-hand understanding of the challenges in the healthcare sector and its rapid growth to date, we are in no doubt that Semble is well poised to seize this massive market opportunity.”
The post London-based Semble raises $15M from Octopus Ventures and others to help medical practitioners save time appeared first on Tech Funding News.